United States · FDA National Drug Code directory
Ranolazine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50268-723_47fc05ed-b529-4ae7-e063-6394a90ae1dd
- Product NDC
- 50268-723
- Form
- TABLET, FILM COATED, EXTENDED RELEASE
- Composition / generic term
- Ranolazine
- Labeler
- AvPAK
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220920
- Source listing expiry
- 20271231
Source-listed ingredients
- RANOLAZINE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 BLISTER PACK in 1 BOX (50268-723-13) / 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (50268-723-11) · 50268-723-13
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →